Form 4: Precigen CFO Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Precigen, Inc. reports that Chief Financial Officer Harry Thomasian Jr. sold 41,884 shares of common stock to cover tax obligations upon the vesting of restricted stock units.
Summary
- Harry Thomasian Jr., Chief Financial Officer of Precigen, Inc., reported a transaction on May 28, 2026.
- The transaction involved the sale of 41,884 shares of Precigen common stock.
- These shares were sold to cover tax withholding obligations related to the vesting of restricted stock units on May 23, 2026.
- The sale price was $4.36 per share.
- Following this transaction, Thomasian beneficially owns 554,535 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While an executive selling shares can be a negative signal, the 'sell-to-cover' nature for tax obligations makes it a routine transaction without inherent negative implications for the company's performance.
Positives
- The sale was a 'sell-to-cover' transaction, indicating it was to satisfy tax obligations rather than a discretionary sale of stock.
- The reporting person continues to hold a significant number of shares (554,535) directly.
Negatives
- A notable number of shares were sold by a key executive, which could be perceived negatively by the market, although it was for tax purposes.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While sales by executives can sometimes signal concerns, 'sell-to-cover' transactions for tax withholding are routine and generally not indicative of negative sentiment towards the company's prospects.
Stakeholder Impact
- Shareholders: The sale is for tax purposes and not necessarily indicative of a lack of confidence in the stock, but any executive sale can create short-term market perception shifts.
- Employees: This transaction relates to executive compensation and equity awards, a standard component of employee incentives.
- Management: Highlights the financial planning required by executives to manage tax liabilities arising from equity compensation.
Key Dates
| Date | Description |
|---|---|
| 05/23/2026 | Vesting of restricted stock units. |
| 05/28/2026 | Transaction date for the sale of common stock. |
| 06/01/2026 | Date of signature for the Form 4 filing. |
Keywords
Precigen, PGEN, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.